Peptide Profile
Tirzepatide
The dual-action powerhouse that targets both GIP and GLP-1 receptors, delivering the most dramatic weight loss results ever seen in a medication—averaging over 20% body weight reduction while also crushing blood sugar levels in people with diabetes.
Dose Range
2.5-15mg
Frequency
Once weekly
Route
Subcutaneous injection
Cycle Length
Ongoing/indefinite
Onset
Moderate (1-2 weeks)
Evidence
Strong
Compound Profile
Scientific & Efficacy Data
C225H348N48O68
Molecular Formula
4813.45 g/mol
Molecular Weight
Approximately 5 days (120 hours)
Half-Life
~80% (subcutaneous)
Bioavailability
2023788-19-2
CAS #
168009818
PubChem ID ↗
Developed By · 2016
Eli Lilly Research Team
Eli Lilly and Company
Primary Benefits
Produces 20%+ average body weight loss at the highest dose—the most effective weight loss medication ever approved, approaching surgical results
Dual GIP/GLP-1 activation creates powerful, sustained appetite suppression that makes portion control feel effortless rather than a constant battle
Outperformed semaglutide head-to-head for diabetes management, with HbA1c reductions exceeding 2 percentage points in clinical trials
Amino Acid Sequence
Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(C20 fatty diacid-γGlu-2xOEG)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2Dosing
How much
do I take?
Starting Dose
2.5 mg
This introductory dose helps your body adjust to the medication and minimizes GI side effects. Don't expect much weight loss yet—this phase is all about building tolerance. Think of it as your body's training wheels period.
Standard Dose
5-10 mg
After 4 weeks at 2.5mg, increase to 5mg. Stay here for at least 4 weeks, then move to 7.5mg, then 10mg. This gradual climb reduces side effects while ramping up the weight loss. Most people start seeing serious results at 5-10mg doses.
Advanced Dose
12.5-15 mg
The 15mg dose delivers maximum weight loss—averaging over 20% of body weight in trials. Continue increasing by 2.5mg every 4 weeks until reaching 15mg or your optimal maintenance dose. This is where the jaw-dropping results happen.
Timing
Best time to take
Pick any day of the week that works for you and stick with it. Many people choose a weekend day so they can rest if they experience mild nausea. The exact time of day doesn't matter much thanks to the long half-life—just be consistent.
With food?
Tirzepatide injections can be taken with or without food—it won't affect how the medication works. However, because it slows stomach emptying significantly, eating smaller meals will help you avoid nausea and discomfort. Avoid large, fatty meals.
If stacking
Tirzepatide is typically used as a standalone weight management therapy. If you have diabetes and take insulin or sulfonylureas, those doses will likely need to be reduced to prevent low blood sugar. Always coordinate with your healthcare provider before combining medications.
Adjusting Your Dose
Increase if
- +You've tolerated the current dose for 4+ weeks without significant GI problems
- +Weight loss has slowed or plateaued and you haven't reached the maximum dose
- +Blood sugar targets aren't being met (for diabetes patients)
- +Your healthcare provider recommends continuing the titration schedule
Decrease if
- -Nausea, vomiting, or diarrhea are severe and don't improve after a few weeks
- -You're unable to eat enough to maintain basic nutrition
- -You experience signs of dehydration from persistent GI symptoms
- -Side effects significantly impact your daily life and functioning
Signs of right dose
- ✓Steady weight loss of 1-2+ pounds per week
- ✓Feeling genuinely satisfied with smaller portions
- ✓Reduced food cravings and less thinking about food
- ✓Minimal or manageable GI side effects
Dosing Calculator
Calculate Your Exact Dose
Step 1: Peptide Weight
Find the weight printed on your peptide vial label
Look here!
The peptide weight is printed on the label
Look here!
The weight is on the label
Suitability
Is this
right for me?
Best For
People Who Want Maximum Weight Loss Results
If you're serious about losing significant weight, tirzepatide delivers results that were previously only achievable through bariatric surgery. Clinical trials showed average weight loss exceeding 20% of body weight—that's 50+ pounds for someone starting at 250 pounds. No other medication comes close.
Those Who Haven't Succeeded with Semaglutide
Thanks to its dual GIP/GLP-1 mechanism, tirzepatide often works better for people who had limited results with GLP-1-only drugs like semaglutide. The added GIP activation provides extra metabolic benefits that can break through plateaus and deliver superior weight loss.
People with Type 2 Diabetes Needing Aggressive Control
Head-to-head trials proved tirzepatide beats semaglutide for blood sugar control. The average HbA1c reduction of over 2 percentage points means many people can dramatically reduce or eliminate other diabetes medications. It's a genuine game-changer for metabolic health.
Individuals Looking to Transform Their Relationship with Food
Tirzepatide doesn't just reduce hunger—it fundamentally changes how food appeals to you. Users describe feeling free from constant food thoughts, finding it easy to stop eating when satisfied, and losing interest in formerly irresistible treats. It's not willpower—it's biochemistry working for you.
Consider Alternatives If
Who Should Avoid
Do not use if
- ×You or a family member has had medullary thyroid carcinoma (MTC)—tirzepatide caused thyroid tumors in animal studies
- ×You have Multiple Endocrine Neoplasia syndrome type 2 (MEN2)—elevated thyroid cancer risk
- ×You've had a serious allergic reaction to tirzepatide or any GLP-1/GIP medication
- ×You currently have or recently recovered from pancreatitis—incretin drugs may increase risk
- ×You are pregnant or trying to become pregnant—stop tirzepatide at least 1 month before conception
- ×You are breastfeeding—it's unknown if tirzepatide passes into breast milk
Use with caution if
- !You have a history of gallbladder disease or gallstones—rapid weight loss increases gallstone risk significantly
- !You have diabetic retinopathy—rapid blood sugar improvement can temporarily worsen eye problems
- !You take insulin or sulfonylureas—doses will likely need reduction to prevent dangerous low blood sugar
- !You have severe GI disorders like gastroparesis—tirzepatide substantially slows stomach emptying
- !You have a history of depression or suicidal thoughts—monitor mood changes closely
- !You have kidney disease—GI side effects can cause dehydration that worsens kidney function
Administration
How do I
use it?
Reconstitution
What you need
- •Pre-filled tirzepatide single-dose pen (Mounjaro or Zepbound)—no mixing required
- •Alcohol swabs for injection site cleaning
- •Sharps container for safe pen disposal
- •Calendar or reminder app for weekly dosing
Injection
Route
Subcutaneous injection (into the fatty tissue just under the skin)—the pen makes it quick and virtually painless, and you can easily do it yourself at home
Best sites
- •Abdomen (stomach area)—at least 2 inches from belly button, most popular choice
- •Front of thighs—middle section of the upper leg
- •Back of upper arm—outer area, may need assistance from someone else
Technique
- 1.Remove pen cap and check the medicine window—solution should be clear and colorless
- 2.Clean your injection site with an alcohol swab and let it air dry completely
- 3.Remove the base cap to reveal the needle (it's hidden until you're ready)
- 4.Press the pen firmly against your skin at a 90-degree angle
- 5.Press and hold the purple injection button until you hear two clicks
- 6.Keep the pen pressed against your skin until the gray plunger is visible (about 5-10 seconds)
- 7.Remove the pen and dispose of the entire pen in a sharps container—each pen is single-use
Storage
Signs of degradation
Sample Daily Schedule
Safety
Is it
safe?
Safety Profile
Tirzepatide has been extensively studied in the SURPASS (diabetes) and SURMOUNT (obesity) trial programs, involving thousands of participants over multiple years. The FDA approved it after thorough safety review. While GI side effects are common (especially during dose increases), they're typically mild to moderate and improve over time. Serious adverse events are rare. The SURPASS-CVOT trial is ongoing to evaluate long-term cardiovascular outcomes.
Safety data comes from multiple Phase 3 trials with follow-up extending beyond 72 weeks. The overall safety profile is similar to GLP-1-only medications like semaglutide, with GI symptoms being the most frequent issues. The thyroid tumor risk seen in rodents has not been confirmed in humans, but remains a theoretical concern requiring ongoing monitoring.
Common Side Effects
Experienced by some users
Nausea
The most frequently reported side effect, affecting about 25-30% of users. It's usually worst during the first few weeks and when increasing doses, then typically fades as your body adjusts.
Management: Eat smaller, more frequent meals. Avoid greasy, fried, or heavy foods. Stay upright after eating. Ginger tea or ginger candies can help. The slow dose escalation protocol is designed to minimize this—don't rush the titration.
Diarrhea
Affects about 15-20% of users, particularly during dose increases. Your digestive system is adjusting to significantly slower stomach emptying and changed gut signaling.
Management: Stay well hydrated with water and electrolytes. Avoid caffeine and alcohol which can worsen symptoms. Consider a probiotic. Over-the-counter anti-diarrheals can help if needed. Usually improves within a few weeks.
Decreased Appetite
This is actually how tirzepatide works—it's the intended effect, not a side effect. You'll genuinely feel less hungry and more satisfied with smaller amounts of food.
Management: While reduced appetite is the goal, don't skip meals entirely. Focus on nutrient-dense, protein-rich foods at each meal. Aim for at least 60-80g of protein daily to preserve muscle mass. Set reminders to eat if you're forgetting meals.
Vomiting
About 10-15% of users experience vomiting, especially during the titration phase. Like nausea, it's typically temporary and improves as your body acclimates.
Management: If vomiting is persistent, contact your healthcare provider—they may recommend staying at your current dose longer before increasing. Ensure adequate hydration. Anti-nausea medications may be prescribed if needed.
Less Common
- •Gallbladder Problems
- •Hair Thinning (Telogen Effluvium)
These typically resolve with continued use or dose adjustment.
Stop and Seek Help If
- ×Severe or persistent GI symptoms that prevent adequate nutrition despite dose adjustments and supportive care
- ×Signs of pancreatitis—severe abdominal pain radiating to the back requiring emergency evaluation
- ×Allergic reaction—rash, hives, itching, facial swelling, or difficulty breathing
- ×Signs of thyroid problems—neck lump, persistent hoarseness, difficulty swallowing
- ×Pregnancy or planning to become pregnant (stop at least 1 month before attempting conception)
- ×Severe kidney problems or persistent dehydration from GI symptoms
- ×Your healthcare provider recommends discontinuation for any reason
Tirzepatide is a prescription medication that should only be started, adjusted, or stopped under medical supervision. This information is for education only and does not replace professional medical advice. While stopping tirzepatide abruptly is generally safe, discuss any changes with your healthcare provider. Weight regain is common after discontinuation.
Interactions
With other peptides
- !Never combine GLP-1 medications—they work through overlapping mechanisms. Combining would dramatically increase side effects without additional benefit.
- ✓No direct interaction data exists. BPC-157 is sometimes used for gut healing which could theoretically help with GI side effects, but this is speculative and unstudied.
- ✓Limited interaction data available. Both can affect glucose metabolism, so combining should only be done under close medical supervision.
With medications
- !Insulin - Tirzepatide dramatically enhances insulin's blood sugar-lowering effect. Insulin doses typically need reduction of 20-50% or more when starting tirzepatide to prevent dangerous hypoglycemia. Close monitoring essential.
- !Sulfonylureas (glipizide, glyburide, glimepiride) - High hypoglycemia risk when combined. Sulfonylurea doses usually need significant reduction. Monitor blood sugar frequently and watch for symptoms of low blood sugar.
- ✓Oral Contraceptives - Tirzepatide's effect on gastric emptying may alter absorption of oral medications. Consider using alternative or backup contraception, especially during dose changes.
- ✓Warfarin - May affect warfarin absorption and metabolism. Increased INR monitoring recommended when starting tirzepatide or changing doses.
- ✓Acetaminophen and other oral medications - Significantly delayed gastric emptying may slow absorption of oral medications. Consider timing and discuss with your pharmacist.
With supplements
- ✓Vitamin B12 - Long-term use of incretin medications may reduce B12 absorption. Consider B12 supplementation, especially if you've been on tirzepatide for over a year.
- ✓Fiber Supplements - Can help manage constipation but start slowly—too much fiber too fast can worsen GI symptoms. Psyllium husk is a gentle option.
- ✓Protein Supplements - Highly recommended to preserve muscle mass during rapid weight loss. Aim for 1g protein per pound of goal body weight, or at least 60-80g daily.
- ✓Electrolyte Supplements - Helpful if experiencing diarrhea or vomiting to prevent dehydration and electrolyte imbalances.
Effectiveness
Does it
work?
Evidence Level
Strong human trials
What to Expect
Weeks 1-4 (2.5mg dose)
What you might notice
- •Mild nausea, especially after eating larger meals
- •Possibly feeling slightly fuller than usual
- •Minimal to no weight loss yet—this is normal and expected
- •Some people feel almost nothing at this dose—that's completely fine
What's normal
- •GI symptoms that come and go throughout the day
- •Still feeling hungry between meals
- •Weight staying about the same or losing just 1-2 pounds
- •Getting comfortable with your weekly injection routine
What's next
- →After 4 weeks, increase to 5mg
- →Continue eating normally—don't force dietary changes yet
- →Establish your consistent weekly injection day
Weeks 5-16 (5-10mg doses)
What you might notice
- •Noticeably reduced appetite and less thinking about food
- •Feeling genuinely satisfied with smaller portions
- •Weight loss becoming visible—typically 5-10% of starting weight
- •GI side effects may briefly intensify with each dose increase, then improve
What's normal
- •Temporary nausea for a few days after each dose increase
- •Smaller meals feeling completely satisfying
- •Significant reduction in food cravings and snacking urges
- •Clothes starting to fit differently
What's next
- →Continue gradual dose increases every 4 weeks (5mg → 7.5mg → 10mg)
- →Prioritize protein at every meal to preserve muscle
- →Start noticing how your relationship with food is fundamentally changing
Weeks 17-28 (12.5-15mg doses)
What you might notice
- •Powerful appetite suppression—you may need reminders to eat
- •Steady, significant weight loss of 2+ pounds per week
- •Food cravings dramatically reduced or absent
- •GI symptoms typically stabilizing by now
What's normal
- •Eating 30-50% less than before starting, without feeling deprived
- •Much less interest in formerly irresistible foods
- •Visible physical transformation—face, waist, body composition
- •Improved energy and mobility as weight comes off
What's next
- →Reach the 15mg maximum dose or find your optimal maintenance level
- →Focus on building sustainable long-term eating patterns
- →Incorporate regular physical activity as you feel more energetic
Months 7-12 and beyond
What you might notice
- •Approaching or exceeding 20% weight loss from starting point
- •Dramatic improvements in metabolic health markers
- •New, healthier relationship with food firmly established
- •Side effects minimal or absent at this stage
What's normal
- •Weight loss rate slowing as you approach a new equilibrium
- •Maintained reduced appetite at your dose
- •Lab improvements in blood sugar, cholesterol, liver enzymes, inflammation
- •Complete wardrobe replacements and comments from everyone you know
What's next
- →Continue maintenance therapy—weight typically returns if medication stops
- →Work with your healthcare team on your long-term plan
- →Focus on lifestyle habits that support maintaining your incredible progress
Signs It's Working
Appetite and Eating Behavior
- ✓Feeling genuinely full and satisfied with much smaller portions
- ✓Fewer food cravings, especially for sweets, snacks, and junk food
- ✓Reduced 'food noise'—that constant mental chatter about what to eat next
- ✓Naturally gravitating toward healthier food choices
- ✓Ability to stop eating when satisfied without internal struggle
- ✓Less emotional or stress eating
Weight and Body Composition
- ✓Scale weight consistently trending downward week after week
- ✓Clothes becoming loose, needing smaller sizes
- ✓Visible changes in face shape, waistline, and overall silhouette
- ✓Waist circumference decreasing measurably
- ✓Before/after photos showing obvious transformation
Metabolic Health (via lab tests)
- ✓Blood sugar levels dropping significantly (HbA1c improving)
- ✓Blood pressure moving toward healthy range
- ✓Cholesterol panel improving—lower LDL, lower triglycerides
- ✓Liver enzymes normalizing if previously elevated
- ✓Inflammatory markers like CRP decreasing
Not Seeing Results?
Common reasons
- •Not at therapeutic dose yet—most weight loss occurs at 10-15mg; lower starting doses are just for adjustment
- •Not giving it enough time—significant results typically require 3-6 months of consistent use at higher doses
- •Eating through the medication—forcing yourself to eat large portions despite feeling full defeats the purpose
- •Choosing calorie-dense foods—even smaller portions of high-calorie foods can stall progress
- •Underlying conditions interfering—thyroid disorders, PCOS, certain medications, or hormonal imbalances may slow results
- •Dehydration affecting the scale—ensure adequate water intake for accurate weight readings
Key Research
"Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)"
Jastreboff AM, Aronne LJ, Ahmad NN, et al., 2022
Finding: This landmark trial proved tirzepatide's extraordinary effectiveness for weight loss. Participants on the 15mg dose lost an average of 20.9% of their body weight over 72 weeks—about 52 pounds. Over half the participants lost more than 20% of their weight, results previously only achievable with surgery.
View Study"Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2)"
Frías JP, Davies MJ, Rosenstock J, et al., 2021
Finding: Head-to-head comparison showed tirzepatide beat semaglutide at every dose level. The 15mg tirzepatide dose reduced HbA1c by 2.30 percentage points versus 1.86 with semaglutide. Weight loss was also significantly greater—5.5kg more weight lost with tirzepatide 15mg compared to semaglutide 1mg.
View Study"Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3)"
Wadden TA, Chao AM, Machineni S, et al., 2023
Finding: For people who had already lost at least 5% of their weight through intensive lifestyle changes, adding tirzepatide produced an additional 18.4% weight loss over 72 weeks. Total weight loss from original starting weight exceeded 25% for many participants.
View Study"Effects of Tirzepatide on Cardiometabolic Risk Factors"
Sattar N, McGuire DK, Pavo I, et al., 2022
Finding: Comprehensive analysis showed tirzepatide improves virtually every cardiovascular risk factor: blood pressure dropped 6-9 mmHg, triglycerides fell 25%, LDL cholesterol decreased, and inflammatory markers improved significantly across all doses studied.
View StudyFrequently Asked Questions